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Abbreviations
TDP-43  TAR DNA binding protein, 43 kDa
FMRP  Fragile X mental retardation protein
CYFIP1  Cytoplasmic FMRP interacting protein 1
FISH  Fluorescence in situ hybridization
RNA-IP  RNA immunoprecipitation
DIV  Day in vitro
DIC  Differential interference contrast
Introduction
Neurodevelopmental disorders result from growth and 
developmental impairments of the brain or central nerv-
ous system. Cognitive and neuropsychiatric problems and 
intellectual disability in patients with these disorders are 
believed to be due to perturbations of synapse functioning 
with connectivity defects [44, 62]. Among the neurodevel-
opmental diseases, Fragile X Syndrome (FXS) is the most 
common inherited disorder, with intellectual impairment 
caused by the mutation of a single gene, FMR1, encoding 
the FMRP protein. Depletion of FMRP in diseased cells 
causes an increase in the translation of a number of pro-
teins important for dendritic spine development [16, 59]. 
Of great genetic and clinical interest is the association of 
FMRP with other neurodevelopmental disorders, including 
autism spectrum disorders (ASD), as well as neurodegener-
ative diseases such as the fragile X-associated tremor ataxia 
syndrome (FXTAS) and Alzheimer’s disease (AD) [28, 65]. 
Significantly, while the genetic causes of the majority of 
ASD cases are unknown, ~5 % of ASD children also have 
FXS, with a mutated FMR1 gene and lower level of FMRP 
protein [22].
In contrast, neurodegenerative diseases are characterized 
by progressive loss of the structure/function of neurons and 
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neuronal death at later stages in life. In neurodegenerative 
diseases such as Huntington’s disease (HD), Alzheimer’s 
disease (AD), frontotemporal lobar dementia (FTLD) and 
amyotrophic lateral sclerosis (ALS), abnormal protein-
folding leads to aggregate formation, resulting in loss-of 
function of multiple proteins and giving rise to disease phe-
notypes [69]. Importantly, different RNA-binding proteins 
(RBPs) are involved extensively in various forms of neu-
rodegenerative diseases and neurodevelopmental disorders 
[30, 58]. RBPs play important roles in RNA processing and 
metabolism, including pre-mRNA splicing, polyadenyla-
tion, transport, surveillance, mRNA localization, mRNA 
stability control, translational control and RNA editing. 
Aberrant expression and mutations in RBP genes affect 
various RNA processing steps and alter the target gene 
expression [25]. There are more than 800 RBPs encoded by 
the human genome and, together, they comprise approxi-
mately 40 different types of domain motifs [54]. Although 
considerable effort has been invested in understanding the 
biological functions of RBPs and the pathogenic mecha-
nisms underlying RBP-associated diseases, a number of 
questions remain to be addressed.
TDP-43 is a ubiquitously expressed RNA-binding pro-
tein required for early development [68], and it has been 
implicated in multiple cellular processes including cell 
cycle progression, apoptosis, RNA processing, alternative 
splicing, etc., despite little being known about its associ-
ated mechanisms [4, 38, 42, 67]. TDP-43 binds at UG-rich 
sequence(s) on single-stranded RNAs with high affinity via 
its two RNA-binding domains, RRM1 and RRM2 [4]. Mis-
metabolism of this protein, including the formation of cyto-
plasmic TDP-43(+) and ubiquitin(+) aggregates (TDP-43 
proteinopathies), appears to be associated with the major-
ity of ALS (ALS-TDP) and FTLD (FTLD-TDP) cases [29, 
42, 49]. Numerous putative RNA substrates for TDP-43 
binding, including TDP-43 mRNA itself, have been identi-
fied by global or targeted analyses which suggest its role 
in regulating the architecture and functions of neurons and 
synapses [52, 57, 61]. This is consistent with TDP-43 loss-
of-neuronal-function being one of the major causes for the 
development of neurodegenerative diseases through TDP-
43 proteinopathies [41, 69]. On the other hand, gain-of-tox-
icity has also been suggested to contribute to the pathogen-
esis of ALS-TDP and FTLD-TDP [8, 41, 63].
Several studies have suggested that one of the func-
tions of TDP-43 in neurons is to regulate translation. First, 
TDP-43 represses translation in an in vitro system [66]. 
Second, TDP-43 interacts with translational regulators, 
including FMRP and several heterogeneous ribonucleo-
protein particles (hnRNPs) [24]. Third, in a Drosophila 
ALS model with over-expression of human TDP-43 in 
the motor neurons, translation of futsch (the Drosophila 
ortholog of human Map1b) appears to be impaired [14] 
and this impairment is partially rescued by overexpression 
of FMRP [15]. Finally, expression of one of the positive 
regulators of spinogenesis, Rac1, appears to be controlled 
by TDP-43 at the level of translation [45]. Despite these 
indications, whether TDP-43 directly regulates translation 
in neurons in vivo is still unclear and, if it does, the mech-
anistic details of TDP-43-mediated translational regulation 
are unknown.
Unlike TDP-43, FMRP is a well-established repressor 
of translation and it acts by blocking either the initiation 
or elongation step [12]. Approximately 4 % of mouse brain 
mRNAs interact with FMRP. Furthermore, FMRP can 
directly bind mRNAs that possess the G-quadruplex struc-
ture through one of its three RNA-binding domains [46, 
64]. It has also been suggested that the association between 
FMRP and mRNAs may require yet to be identified adap-
tor proteins [20, 48] or RNAs such as BC1 [72]. In an FXS 
mouse model, loss of FMRP causes an increased global 
level of protein synthesis [50], resulting in a high density 
of dendritic spines [10] as well as affecting the brain devel-
opment and synaptic plasticity [59]. Notably, the increased 
dendritic spine density and likely the FXS pathology could 
be attributed in part to an increase of Rac1 protein expres-
sion due to the loss of FMRP [6]. Furthermore, FMRP is 
associated with Rac1 mRNA in ribonucleoprotein (RNP) 
granules [40]. This is in interesting parallel to the suggested 
regulatory role of TDP-43 in the translation of Rac1 mRNA 
and spinogenesis in hippocampal neurons, as revealed by 
the change in Rac1 protein amount, but not Rac1 mRNA 
levels and/or Rac1 protein stability, upon over-expression 
or knockdown of TDP-43 [45].
Here, we show for the first time a functional and mecha-
nistic link between TDP-43 and FMRP in the translational 
regulation of several FMRP target mRNAs important for 
synaptic plasticity. Using Rac1 mRNA as the paradigm, 
we demonstrate that TDP-43 acts as an adaptor protein to 
recruit the FMRP-CYFIP1 inhibitory complex to mRNAs, 
thereby repressing the initiation of translation. This is an 
important advancement towards understanding the molec-
ular mechanisms of both RBPs in translational regulation 
and unraveling the overlap between FMRP-associated neu-
rodevelopmental disorders and neurodegenerative diseases 
at the molecular level.
Materials and methods
Primary mouse hippocampal neuronal culture 
and HEK293T cell culture
The 14 day pregnant FVB mice were obtained from the 
National Laboratory Animal Center of Taiwan. The prepa-
ration of primary hippocampal neurons in culture followed 
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the standard protocols using cells mechanically dissociated 
from the hippocampi of E16.5–17.5 mouse embryos [45]. 
For the study of translational repression, cultured neurons 
were treated with the translational inhibitor 4EGI-1(Merck 
Millipore, Germany) at a final concentration of 25 μM for 
30 min to 1 h before harvesting for further analysis.
Human HEK293T cell culture was grown at 37 °C in 
DMEM containing 10 % fetal bovine serum, 100 U/ml 
penicillin, and 100 g/ml streptomycin.
Plasmid construction
See Supplementary Experimental Procedure for detailed 
description of the different plasmids used in the study.
Transfection of plasmid DNAs and RNAi oligos
For details, see Supplementary Experimental Procedures.
Western blotting and RT‑PCR analysis
For details, see Supplementary Experimental Procedures.
Immunofluorescence staining
Details of the immunofluorescence staining experiments of 
the primary hippocampal neurons are described in Supple-
mentary Experimental Procedures.
Fluorescence in situ hybridization (FISH) 
and combined immunofluorescence (IF) staining
For details, see Supplementary Experimental Procedures.
Polysome profile analysis
The analysis followed the general procedures [39]. For 
details, see Supplementary Experimental Procedures.
RNA‑IP
RNA-IP was used to study the protein-RNA interactions. 
For details see Supplementary Experimental Procedures.
Immunoprecipitation (IP)
For details, see Supplementary Experimental Procedures.
In vitro RNA–protein binding assay using biotinylated 
oligoneucleotides
The procedures followed those described before [7]. For 
details see Supplementary Experimental Procedures.
Dual‑luciferase reporter assay of translation
For details, see Supplemental Experimentary Procedures.
Local dendritic translation assay
The details of the analysis by a reporter assay are described 
in Supplementary Experimental Procedures.
Results
Regulation of Rac1 mRNA translation by TDP‑43 
and FMRP in primary hippocampal neurons 
and non‑neuronal cells
To unequivocally demonstrate that TDP-43 and FMRP 
regulate Rac1 mRNA translation, we transfected DIV 6 
primary hippocampal neurons with different RNAi oligos 
including control Sc oligo, TDP-si oligo or FMRP-si oligo 
([45, 53]; see Supplementary Materials and Methods for 
more details). As expected from previous studies [6, 45], 
Western blotting showed a significant increase in Rac1 pro-
tein levels upon depletion of either TDP-43 or FMRP by 
RNAi (Fig S1a). We then compared the polysome profiles 
of the cytoplasmic extracts from the different RNAi oligo-
transfected primary hippocampal neurons by sucrose gradi-
ent sedimentation analysis. The polysome profiles of DIV 
6–8 primary neurons, as exemplified on top of Fig. 1a(i), 
were similar to those of DIV 4–7 primary cortical neu-
rons [34]. Significantly, while depletion of either TDP-43 
or FMRP did not impair the global cellular translation sta-
tus as reflected by the polysome profiles (data not shown), 
polysomal accumulation of Rac1 mRNA, but not of Gapdh 
mRNA, at the expense of its association with 40S and 
60S/80S monosomes was evident in TDP-si or FMRP-si 
transfected cells [results from three biological repeats have 
been presented in Fig. 1a(ii) and results of three technical 
repeats from single biological sample was exemplified in 
Fig S1b]. Repression of Rac1 translation by TDP-43 and 
by FMRP in the primary hippocampal neurons, as reflected 
by the polysome profile analysis, was consistent with the 
[35S]-metabolic labeling and IP experiments (Fig S1c).
We also examined the distributions of TDP-43 and 
FMRP proteins in the sucrose gradients. As shown by West-
ern blotting [bottom panel, Fig. 1a(i)], both proteins were 
co-fractionated mainly with mRNPs, 40S, and partially 
with 60S/80S. Notably, the distribution of FMRP-contain-
ing RNP complexes in sucrose gradients has been studied 
by many groups because of its important role in translation. 
Surprisingly, different groups have found prominent differ-
ences in the distribution patterns of FMRP in sucrose gra-
dient fractions. It was reported to be co-sedimenting with 
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the translating polyribosomes [17, 33], equally distributed 
between the polysomes or monosomes and mRNPs [5, 9, 
27], or mostly non-polysomal and associated with the trans-
lation initiation complexes [48, 71]. These discrepancies 
could be caused in part by differences in the extract prepa-
ration procedures and/or the different sources from which 
the extracts were prepared [60]. In any case, as shown in 
Fig. 1a(i), we found that distribution pattern of FMRP pro-
tein in the polysome profile of DIV 6-8 primary hippocam-
pal neuron extract was different from that of the ribosomal 
protein rpL6 but similar to those of the translational regula-
tors eIF4E and CYFIP1, which were known to interact with 
FMRP to inhibit translation at the initiation step [48]. Thus, 
our results indicated that FMRP in the hippocampal neu-
rons might function in the inhibition of the translation ini-
tiation as reported before for the synaptoneurosomes [48]. 
The similar distribution patterns of TDP-43 and FMRP fur-
ther suggested that TDP-43 might reside within the same 
complex(es) with FMRP, CYFIP1, eIF4E, and perhaps also 
with some of the translationally silent mRNAs.
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The polysome profiles of HEK293T cells, as exempli-
fied in Fig. 1b(i), were similar with or without exogenous 
expression of Flag-TDP-43 or depletion of endogenous 
TDP-43 or FMRP by respective RNAi (data not shown). 
Notably, the polysome profiles and FMRP distribution pat-
tern shown in Fig. 1b(i) were similar to those of the pri-
mary hippocampal neurons [Fig. 1a(i)] and lymphoblast 
cell lines [9]. Interestingly, the exogenous Flag-TDP-43 
partially co-sedimented with FMRP and CYFIP1 [bot-
tom panel, Fig. 1b(i)], suggesting that exogenous TDP-43 
resided in the translation inhibitory complexes containing 
the endogenous FMRP and CYFIP1. Furthermore, the level 
of Rac1 mRNA, but not Gapdh mRNA, in the monosomal 
fractions was increased with a concomitant decrease in the 
polysomal fractions upon over-expression of Flag-TDP-43 
(results from three biological repeats have been presented 
in Fig. 1b(ii) and results of three technical repeats from sin-
gle biological sample was exemplified in Fig S1d). Finally, 
it was interesting to note that, the decrease of Rac1 mRNA 
in the polysomal fractions could be partially rescued by 
depletion of FMRP using the FMRP-si oligo [Fig. 1b(ii)]. 
Together, these data suggest that TDP-43 and FMRP might 
reside in the same mRNP complexes and that TDP-43 
inhibits Rac1 mRNA translation in a FMRP-dependent 
manner.
Physical interaction of TDP‑43 with Rac1 mRNA 
and FMRP
To further understand the regulation of Rac1 mRNA trans-
lation by TDP-43 and FMRP, we first tested whether TDP-
43 and FMRP could form an RNP complex together with 
Rac1 mRNA. RNA-immunoprecipitation assays (IP) of 
primary hippocampal neuronal cell extracts were carried 
out using anti-TDP-43 and anti-FMRP under conditions 
that preserved native protein-RNA complexes. The lev-
els of Rac1 mRNA in the immunoprecipitated complexes 
were compared by quantitative [Fig. 2a(i)] and semi-quan-
titative [Fig. 2a(ii)] RT-PCR. In comparison to the control 
IgG, Rac1 mRNA was significantly enriched in the anti-
TDP-43 or anti-FMRP immunoprecipitated complexes. 
However, the binding of FMRP to Rac1 mRNA was sig-
nificantly decreased upon TDP-43 depletion, whereas only 
marginal or no decrease in the binding of TDP-43 was 
detected upon FMRP depletion [Fig. 2a(i)]. Data from the 
semi-quantitative RT-PCR analysis were consistent with 
the results of the quantitative RT-PCR analysis [compare 
lanes 4–6, Fig. 2a(ii)]. Thus, the binding of TDP-43 to 
Rac1 mRNA was independent of FMRP, whereas FMRP 
was recruited to Rac1 mRNA-containing RNPs in a TDP-
43-dependent manner. Consistent with the above, Western 
blot analysis showed that proteins isolated from RNA-IP 
complexes pulled-down by anti-TDP-43 contained TDP-
43 as well as FMRP (compare lane 4 with other lanes, 
Fig. 2b).
To investigate whether TDP-43 directly interacted with 
Rac1 mRNA, we used an in vitro transcription reaction 
protocol to generate biotin-labeled RNA probes corre-
sponding to the 5′-untranslated region (5′UTR, probe 
A), the coding sequence (CDS, probe B), and two parts 
of the 3′-untranslated region (3′UTR, probes C and D) of 
Rac1 mRNA. We also generated three RNA probes from 
3′UTR (C), namely 3′UTR-1, 3′UTR-2, 3′UTR-3, as well 
as mutated forms of these RNA probes harboring base 
changes to disrupt the putative TDP-43-binding UG/GU 
repeats, namely 3′UTR-2-Mt, 3′UTR-3-Mt, 3′UTR-3-Mt1 
and CDS-Mt [left map, Fig. 3a(i)]. Purified probes were 
incubated with avidin-conjugated beads and extracts from 
HEK293T cells expressing Flag-TDP-43. As seen, TDP-
43 could be pulled down by probes B, C [right panels of 
Fig. 3a(i)], CDS, 3′UTR-3 and 3′UTR-2 [lanes 1, 3 and 
6, Fig. 3a(ii)], but not by 5′UTR (A), 3′UTR-4(D) [right 
panels of Fig. 3a(i)] or 3′UTR-1(data not shown). As 
expected, similar pull-down experiments demonstrated 
that both RNA-binding motifs of TDP-43 were required 
Fig. 1  Effects of depletion of TDP-43/FMRP or over-expression of 
TDP-43 on the polysomal distribution of Rac1 mRNA. a Polysomal 
distribution of different proteins (i) and mRNAs (ii) in mouse primary 
hippocampal neurons. Cytoplasmic extracts, from cultured DIV 6 
neurons transfected with different siRNA oligos, were separated by 
sucrose gradient sedimentation. i Top, representative polysome profile 
of DIV 6 primary hippocampal neurons. Bottom, different fractions 
of the sucrose gradient loaded with extract from Sc oligo-transfected 
hippocampal neurons were analyzed by Western blotting using dif-
ferent antibodies. ii Quantitative RT-PCR analysis of Rac1 mRNA in 
40S monosome (left histogram), 60S/80S monosomes (middle histo-
gram), and polysome (right histogram) fractions of DIV 6 primary 
hippocampal neurons transfected with Sc, TDP-si and FMRP-si oli-
gos. The experiments were repeated 3 times for each of three differ-
ent preparations of neuron culture (N = 3). Statistical significance 
between control Sc oligo and TDP-si or FMRP-si oligo transfected 
neurons was determined by Student’s t test: ***p < 0.0001 and 
**p < 0.001. Inputs were similar (data not shown). The graphs of 
polysomal distribution from use of one of the three biological sam-
ples are exemplified in Fig S1b. b Polysomal distributions of Rac1 
mRNAs in HEK293T cells with ectopic expression of TDP-43 and/
or depletion of FMRP by FMRP-si oligo. i Top, Representative poly-
somal profile of HEK293T cells. Bottom, Western blot analysis of the 
distribution patterns of different proteins in the polysomal fractions 
of HEK293T cells over-expressing pFlag-TDP-43. ii Quantitative 
RT-PCR analysis of Rac1 mRNA in 40S monosome (left histogram), 
60S/80S monosomes (middle histogram), and polysome (right his-
togram) fractions of HEK293T cells transfected with pFlag, pFlag-
TDP-43 ± FMRP-si oligo. The experiments were repeated 3 times 
for each of three different sets of extract preparation (N = 3). Signifi-
cant differences among the three groups were determined by one way 
ANOVA, ***p < 0.0001. Inputs were similar (data not shown). The 
graphs of polysomal distribution from use of one of the three biologi-
cal samples are exemplified in Fig S1d
◂
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for effective binding with Rac1 mRNA [Fig. 3a(iii)]. In 
parallel, interactions between TDP-43 and 3′UTR-2, 
3′UTR-3 or CDS were mostly abolished by the 3′UTR-
2-Mt, 3′UTR-3-Mt and CDS-Mt mutations, respectively 
[lanes 2,5 and 7, upper panel of Fig. 3a(ii)], but not by 
3′UTR-3-Mt1 [lane 4, upper panel of Fig. 3a(ii)]. Sig-
nificantly, Western blotting analysis of the RNA probe-
pulled-down samples using anti-FMRP revealed that RNA 
probes 3′UTR-2, 3′UTR-3 and mutated probe 3′UTR-
3-Mt1, but not 3′UTR-2-Mt, 3′UTR-3-Mt, CDS and CDS-
Mt, could efficiently pull-down endogenous FMRP [mid-
dle panel of Fig. 3a(ii)]. Whereas more structural studies 
would be needed to fully understand the nature of the 
physical interaction of TDP-43 and FMRP protein with 
Rac1 mRNA, the data of Figs. 2 and 3a together dem-
onstrate that TDP-43 can bind to the 3′UTR and coding 
sequence of Rac1 mRNA at specific UG/GU dispersed 
repeats, but FMRP can only be associated with the 3′UTR 
of Rac1 mRNA and that this association is most likely 
mediated through recruitment of FMRP by the 3′UTR-
bound TDP-43.
Translational co‑repression of Rac1 mRNA mediated 
by TDP‑43 and FMRP
Luciferase reporter assays were used to map the regions 
of Rac1 mRNA required for translational repression by 
TDP-43. 5′UTR, CDS and different 3′UTR fragments or 
their mutant counterparts were cloned into the dual lucif-
erase vector psicheck2 and co-transfected with pFlag or 
pFlag-TDP-43 into HEK293T cells. Since the amounts 
of luciferase mRNAs were similar among different sets 
of transfected HEK293T cells [Fig S2a], any change in 
relative luciferase activity would occur at the transla-
tional level. As shown in Fig S2b, Flag-TDP-43 inhib-
ited translation of the reporter RNAs containing 3′UTR-2 
and 3′UTR-3 by 40 and 30 %, respectively, whereas the 
translation of the reporter RNAs containing 3′UTR-1, 
3′UTR-4, 5′UTR or CDS were not inhibited. This data 
suggests that TDP-43 bound to the 3′UTR of Rac1 mRNA 
represses translation, but that the complex formed at the 
CDS harboring Flag-TDP-43 had no effect on transla-
tion. Thus, we also analyzed translational repression of 
Fig. 2  TDP-43 associated recruitment of FMRP in mRNP complex 
containing Rac1 mRNA in vivo. a RNA-IP. Total cellular extracts of 
cultured hippocampal neurons transfected with Sc, TDP-si or FMRP-
si were immunoprecipitated with different antibodies, and the immu-
noprecipitated RNAs were analyzed (N = 3) by quantitative (i), pre-
sented as fold enrichment normalized to Sc-IgG, or semi-quantitative 
(ii) RT-PCR using primers specific for Rac1 mRNA. Hdac6 and PSD-
95(Dlg4) mRNAs were also analyzed as positive controls and Gapdh 
mRNA as the negative control. Inputs were similar. Data in (i) are 
presented as mean ± SD, from three independent experiments. Sig-
nificant changes in enrichment of Rac1 mRNA between IgG pulled 
down and anti-TDP-43 or anti-FMRP pulled down samples as well 
as between control Sc oligo and TDP-si or FMRP-si oligo transfected 
neurons are represented by ***p < 0.0001 (Student’s t test). b Iden-
tification of proteins associated with Rac1 mRNA. Proteins isolated 
from RNA-IP complexes were analyzed by Western blotting using 
anti-TDP-43 and anti-FMRP. The experiment was repeated several 
times
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the full-length 3′UTR of Rac1 by a luciferase reporter 
assay. As shown in Fig. 3b, translation of reporter RNA 
comprising the full length 3′UTR of Rac1 was halved by 
exogenous Flag-TDP-43. This repression could be res-
cued by the co-presence of 3′UTR-2-Mt and 3′UTR-3-Mt 
mutations (Fig. 3b).
Fig. 3  Binding and translational repression of Rac1 mRNA by TDP-
43 and FMRP. a In vitro binding assay of TDP-43 to wild type and 
mutated Rac1 mRNA fragments. Biotinylated RNA probes corre-
sponding to different parts of Rac1 mRNA, with or without base sub-
stitutions disrupting the putative TDP-43-binding UG/GU sequences 
(left map in i), were incubated with total cell extracts from HEK293T 
cells over-expressing Flag-TDP-43 (i, ii) and/or different deletion 
mutants of Flag-TDP-43 (iii). Affinity-purified elutes were separated 
on SDS-PAGE and immunoblotted with anti-Flag) top panels in i, ii, 
iii) or anti-FMRP (middle panel in ii). As the loading control, RNAs 
immunoprecipitated by anti-FLAG were also analyzed by semi-quan-
titative RT-PCR using primer set(s) specific for each of the corre-
sponding RNA probes (bottom panels in i, ii, iii). All the experiments 
were repeated at least three times. b Luciferase reporter assay of 
HEK293T cells co-transfected with pFlag-TDP-43 and the psicheck2 
reporter carrying full length wild type/mutant 3′UTR sequences 
of Rac1. Luciferase protein levels in cell extracts prepared at 48 h 
post-transfection were determined and presented as fold changes 
(N = 3), comparing cells co-expressing Flag-TDP-43 relative to 
cells co-expressing Flag. Significant differences in luciferase activity 
between Flag and Flag-TDP-43 transfected cells are represented by 
***p < 0.0001 and *p < 0.01 (Student’s t test). c Luciferase activ-
ity assay of HEK293T cells co-transfected with the reporter contain-
ing Rac1 3′UTR, Sc oligo or FMRP-si oligo, and one or more of the 
following expression plasmids: pFlag, pGFP, pFlag-TDP-43 pGFP-
FMRP, pFlag-TDP-43(ΔGly). Luciferase activities (N = 3) are repre-
sented as the fold change compared to cells transfected with Sc oligo, 
pFlag and pGFP. Rescue1 and Rescue 2 represent significant recovery 
of Rac1-3′UTR-mediated luciferase reporter translation. Significant 
changes are represented by ***p < 0.0001 and **p < 0.001 (Student’s 
t test). The amounts of RNA transcripts from different expression 
plasmids were similar in b and c (data not shown)
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The apparent requirement of FMRP for Flag-TDP-
43-mediated translational repression of Rac1 mRNA 
(Fig. 1) was further established by luciferase reporter 
assays. First, siRNA-driven depletion of endogenous 
FMRP partially rescued (Rescue 1) translational repression 
of the luciferase reporter by Flag-TDP-43 and the 3′UTR 
of Rac1 mRNA [compare the 2nd and 3rd bars from left, 
Fig. 3c]. However, while co-expression of GFP-FMRP 
enhanced the extent of translational repression of the 
reporter by Flag-TDP-43 [compare 2nd and 4th bars from 
left, Fig. 3c], neither the exogenous Flag-TDP-43(ΔGly) 
that lacked the glycine-rich domain of TDP-43 nor Flag-
TDP-43(ΔGly) + GFP-FMRP (Rescue 2) repressed trans-
lation (compare 4th bar with 5th and 6th bars from left, 
Fig. 3c). Notably, the glycine-rich domain of TDP-43 was 
required for its physical interaction with FMRP (compare 
lanes 1 and 2, Fig S3a). That GFP-FMRP alone could not 
significantly inhibit reporter RNA translation (compare the 
right-most bar to the left-most bar, Fig. 3c) might be due 
to the low level of endogenous TDP-43 in HEK293T cells 
[Fig S3b]. For similar reason, TDP-43 depletion by RNAi 
did not change the luciferase activity in HEK293T cells 
in comparison to the control cells (data not shown). These 
results demonstrate that FMRP and TDP-43 cooperatively 
function to repress translation of Rac1 mRNA through 
direct binding of TDP-43 to the 3′UTR region and physical 
interaction between the two RNA-binding factors.
Repression of translation initiation of Rac1 mRNA 
by TDP‑43 through the FMRP‑CYFIP1‑mediated 
pathway
To investigate the mechanisms of translational co-repres-
sion of Rac1 mRNA by TDP-43 and FMRP, we first exam-
ined the effects of a selective inhibitor of eIF4E-eIF4G 
interactions (4EGI-1, [56]), on translation in primary hip-
pocampal neurons. As expected, treatment of cultured neu-
rons with 4EGI-1 led to a marked decrease in polysomal 
RNA content, indicative of global cellular translational 
inhibition [Fig. 4a(i)], as well as decreased level of Rac1 
protein (data not shown). Similar to untreated primary hip-
pocampal neurons (Fig. 1a), prior depletion of TDP-43 or 
FMRP by RNAi had little effect on the global polysome 
profile of 4EGI-1 treated cells (data not shown). However, 
the distribution of Rac1 mRNA (results of three technical 
repeats from single biological sample was exemplified in 
Fig S4a), but not Gapdh mRNA (results of three technical 
repeats from single biological sample was exemplified in 
Fig S4b), was significantly shifted from 40S and 60S/80S 
fractions to polysome fractions by treatment with TDP-si or 
FMRP-si oligo [results from three biological samples have 
been presented in Fig. 4a(ii)]. This shift was accompanied 
by increased levels of Rac1 protein, but not Gapdh, in the 
RNAi-treated neurons (data not shown). These data sug-
gest that inhibition of Rac1 translation by 4EGI-1 at the 
initiation step could be selectively and partially rescued by 
depletion of TDP-43 or FMRP before 4EGI-1 treatment.
Repression of translation by FMRP operates at the ini-
tiation step [48] or elongation step [17], depending on the 
targets and the cellular context. Therefore, we compared 
the effects of the elongation inhibitor cyclohexamide 
(CHX) and the initiation inhibitor 4EGI-1 on translational 
repression of the luciferase reporter psicheck2 carrying 
the 3′UTR of Rac1 mRNA by exogenous TDP-43 and/or 
FMRP in HEK293T cells. As seen in Fig. 4b, Flag-TDP-43 
alone or Flag-TDP-43 + GFP-FMRP suppressed lucif-
erase RNA translation even when elongation was blocked 
by CHX, indicating that elongation is not the rate limiting 
step for TDP-43/FMRP-mediated translational repression 
of Rac1 mRNA. However, cooperative translational repres-
sion was no longer evident when translation initiation was 
inhibited by 4EGI-1. Thus, the rate-limiting step of TDP-
43/FMRP-targeted translational repression of Rac1 mRNA 
is indeed at the initiation step.
FMRP exerts its inhibitory role on translation initiation 
through the eIF4E-binding protein CYFIP1 [48]. Indeed, 
polysome profile analyses of primary hippocampal neurons 
[Fig. 1a(i)] and HEK293T cells [Fig. 1b(i)] showed par-
tial co-sedimentation of TDP-43 and FMRP with CYFIP1, 
suggesting that they might form a complex together with 
mRNAs in vivo. To check whether CYFIP1 played a role in 
TDP-43/FMRP-mediated translational inhibition of Rac1 
mRNA, we carried out RNA-IP analysis of extracts from 
primary hippocampal neurons transfected with control Sc 
oligo, FMRP-si oligo or TDP-si oligo using anti-CYFIP1. 
Significantly, CYFIP1 formed complexes with Rac1 
mRNA, TDP-43, FMRP, as well as with eIF4E proteins 
(lane 1, Fig. 4c). However, the amount of Rac1 mRNA, as 
measured by RT-PCR, in the CYFIP1-pulled down RNP 
complex(s) decreased upon depletion of either FMRP 
or TDP-43 by RNAi (compare lanes 2 and 3 with lane 1, 
bottom 2 panels of Fig. 4c). Furthermore, the amount of 
TDP-43 protein, as examined by Western blotting, in the 
CYFIP1-pulled down RNPs decreased upon FMRP deple-
tion by RNAi (compare lanes 1 and 2 of the top 2 panels, 
Fig. 4c), but the amount of FMRP in the CYFIP1-pulled 
down RNAs was not altered by depletion of TDP-43 (com-
pare lanes 1 and 3 of top 2 panels, Fig. 4c). These data 
suggest that FMRP and TDP-43 together repress the trans-
lation of Rac1 mRNA at the initiation step, and that this co-
repression is achieved through the binding of TDP-43 pro-
tein to the 3′UTR of Rac1 mRNA followed by recruitment 
of the FMRP-CYFIP1 complex that interacts with eIF4E to 
inhibit translation initiation of Rac1 mRNA (Fig. 9; [48]).
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Regulation of local translation of Rac1 mRNA 
by TDP‑43 and FMRP in the hippocampal neurons
We first analyzed Rac1 mRNA localization in DIV 6 and 
DIV 14 hippocampal neuron dendrites. Imaging analysis of 
Rac1 mRNA was carried out by FISH using Rac1 mRNA 
probe 1 (green, Fig. 5a). As shown, most of Rac1 mRNA 
molecules of DIV 6 primary mouse hippocampal neurons 
were confined to the soma [Fig. 5a(i)], while the amount of 
dendritic Rac1 mRNA in DIV 14 hippocampal neurons was 
~8 times higher than that in DIV 6 neurons [bar diagram, 
Fig. 5a(i)]. FISH analysis further indicated that there was 
no significant change in the amount of Rac1 mRNA in DIV 
14 dendrites upon depletion of either TDP-43 or FMRP 
[Fig. 5a(ii)]. Based on the above, we investigated the regu-
lation of local translation of Rac1 mRNA by TDP-43 and 
FMRP in DIV 14 neurons.
Protein synthesis reporters were first constructed in 
which the myr-dEGFP coding sequence was attached to 
Rac1-3′UTR or to different 3′UTR mutants. Since the 
Fig. 4  Translational co-repression of Rac1 mRNA by TDP-43 and 
FMRP at the initiation stage. a Effects of 4EGI-1, TDP-si oligo and 
FMRP-si oligo on polysomal distributions of Rac1 mRNA. i Repre-
sentative polysome profiles of cultured DIV 6 hippocampal neurons 
with or without treatment of 25 µM 4EGI-1 for 30 min. ii Quanti-
tative RT-PCR analysis of Rac1 mRNA in 40S monosome (left his-
togram), 60S/80S monosomes (middle histogram), and polysome 
(right histogram) fractions of DIV 6 primary hippocampal neurons 
transfected with Sc, TDP-si or FMRP-si oligo and with (repre-
sented as ‘4EGI-1’) or without (represented as ‘Mock’) treatment of 
25 µM 4EGI-1 for 30 min. The results are presented by the histobar 
diagrams representing data from three different preparations of pri-
mary neuron culture (N = 3), each with three technical repeats of 
experiments. Significant differences between control Sc oligo and 
TDP-si or FMRP-si oligo transfected neurons as well as between 
Mock and 4EGI-1 treated neurons are represented by ***p < 0.0001 
and **p < 0.001 (Student’s t test). Inputs were similar (data not 
shown). The graphs of polysomal distribution from use of one 
of the three biological samples are exemplified in Fig S4. b Lucif-
erase reporter assay of HEK293T cells transfected with psicheck2-
3′UTR reporter with (pFlag + pGFP), (pFlag-TDP-43 + pGFP) or 
(pFlag-TDP-43 + pGFP-FMRP), followed by treatment with 5 µM 
cyclohexamide (CHX) or 50 µM 4EGI-1 (4EGI-1) for 12 h. Lucif-
erase activities are presented as fold changes relative to that of cells 
transfected with (pFlag + pGFP) and without any drug treatment 
(N = 3). Significant differences among different groups were deter-
mined by one way ANOVA, *p < 0.01. c IP analysis of the associa-
tion of CYFIP1 with TDP-43, FMRP and Rac1 mRNA in DIV 6 pri-
mary hippocampal neurons. Cell lysates from primary hippocampal 
neurons transfected with siRNA oligos were immunoprecipitated 
with anti-CYFIP1 or anti-rabbit IgG, and then analyzed by Western 
blotting (top 4 panels on the right) or by RT-PCR (bottom 2 panels on 
the right). The experiment was repeated for 3 times with the statisti-
cal analysis shown in Fig S6b. Inputs were similar, as shown in the 
left lower 5 panels
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myristoylation peptide (myr) and the short half-life of 
destabilizing dEGFP protein impeded myr-dEGFP synthe-
sized in somata from diffusing to distal dendrites, GFP flu-
orescence intensities in the distal dendritic regions would 
reflect the local protein synthesis [1]. As seen, in spite of 
there being no increase in Rac1 mRNA in DIV 14 den-
drites upon depletion of TDP-43 and FMRP [Fig. 5a(ii)], a 
marked increase in translation was evident in the dendrites 
and somata (Fig. 5b), confirming the role of TDP-43 and 
FMRP in the inhibition of dendritic as well as somatic 
Fig. 5  Rac1-3′UTR-mediated translational co-repression by TDP-43 
and FMRP in hippocampal neuron dendrites. a Imaging analysis of 
Rac1 mRNA by FISH in DIV 6 and DIV 14 hippocampal neurons. i 
Hippocampal neurons at different DIVs were hybridized with Rac1 
probe 1 (green, see Supplementary materials and methods for details) 
and anti-TDP-43 (magenta). The histogram (bottom) compares the 
levels of Rac1 mRNA, presented as fluorescence intensity per 10 µm 
of dendrites of transfected neurons. Each set of data was collected 
from 15 to 18 transfected neurons from three independent experi-
ments. Error bars represent SEM and significant difference is repre-
sented by ***p < 0.0001 (Student’s t test). Scale bar 5 µm. ii FISH 
and immunofluorescence staining analysis of DIV 14 hippocampal 
neurons transfected with Sc, TDP-si or FMRP-si RNA oligo using 
Rac1 probe 1(green, see Supplementary materials and methods for 
details), anti-TDP-43 (magenta), and anti-FMRP (red). The histo-
gram compares the levels of Rac1 mRNA. For each set of samples, 
the data were collected from 10 to 14 transfected neurons from three 
independent experiments. Error bars represent SEM. Scale bar 1 µm. 
Note that we calculated the fluorescence intensity in all FISH experi-
ments using Rac1 anti-sense probe 1 (see Supplementary materials 
and methods for details) in comparison to the control. Furthermore, 
specificity of the FISH experiments was validated by the 60–70 % 
decrease of the fluorescence intensity upon RNAi knock down of 
Rac1 mRNA (Fig S5). b Imaging analysis of DIV 14 hippocampal 
neurons co-transfected with different RNAi oligos and pmyr-dEGFP-
3′UTR as described in Supplementary materials and methods. The 
transfected neurons were probed with anti-TDP-43 or anti-FMRP. 
The distribution patterns of myr-dEGFP proteins expressed in trans-
fected neurons are exemplified by the confocal microscope images 
(top 3 panels). Immunofluorescence from the endogenous TDP-43 
protein (blue) and FMRP protein (red) (middle 3 panels) and DIC 
images (bottom 3 panels) of the same neurons are also shown. Fluo-
rescence intensities of myr-dEGFP protein at near and distal dendrites 
(0–150 and 150–300 µm, left histogram) and soma (right histogram) 
were measured and normalized to Sc oligo-transfected neurons. A 
total of 20–25 neurons from three independent experiments were 
characterized. Error bars represent SEM and significant difference 
is represented by ***p < 0.0001 (Student’s t test). Scale bar 5 µm. 
Note that blockade of the action potentials with tetrodotoxin (TTX) 
significantly decreased expression of myr-dEGFP in distal dendrites 
of TDP-si or FMRP-si transfected neurons (data not shown), support-
ing that myr-dEGFP fluorescence patterns reflect local translation of 
myr-dEGFP-3′UTR mRNA
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translation of Rac1 mRNA. Remarkably, when the locali-
zations of Rac1 mRNA, TDP-43, FMRP and CYFIP1 in 
the dendrites of DIV 14 primary neurons were analyzed by 
combined FISH and immunofluorescence staining, the co-
localization of CYFIP1 with Rac1 mRNA was significantly 
reduced upon either TDP-43 depletion or FMRP depletion 
(right set of histogram, Fig. 6). Notably, co-localization of 
FMRP with Rac1 mRNA was reduced upon depletion of 
TDP-43, but the reverse was not true (compare the left and 
middle sets of the histogram, Fig. 6). These data along with 
those shown in Figs. 2 and 3 indicate that recruitment of 
FMRP and CYFIP1 proteins to Rac1-3′UTR by TDP-43 is 
required for inhibition of localized dendritic translation of 
Rac1 mRNA in hippocampal neurons.
Other mRNA targets of translational co‑repression 
by TDP‑43 and FMRP
FMRP was known to suppress the translation of several 
mRNAs important for synaptic plasticity including Rac1 
mRNA, the impairment of which in part contributed to the 
development of Fragile X Syndrome (FXS) [6]. There-
fore, we investigated whether, besides Rac1 mRNA, TDP-
43 also played a role in regulating the translation of other 
FMRP targets including PSD-95 (Dlg4) mRNA, Map1b 
mRNA, GluR1 (Gria1) mRNA and CamKII mRNA [47, 
72] in comparison to a non-target, i.e., mTOR mRNA. Of 
these targets, TDP-43 neither formed a complex with PSD-
95 mRNA, nor had it any effect on the interaction of FMRP 
with this mRNA [Fig. 2a(ii)].
As shown by RNA IP of extracts from DIV 6 primary 
hippocampal neurons transfected with control Sc oligo, 
TDP-si oligo or FMRP-si oligo, mRNAs encoding Map1b, 
GluR1 and mTOR all interacted with TDP-43 and FMRP, 
whereas CamKII mRNA interacted only with FMRP [lanes 
1 and 4, Fig. 7a(i)]. Moreover, effective recruitment of 
FMRP to Map1b mRNA, GluR1 mRNA or mTOR mRNA, 
but not CamKII mRNA, required TDP-43 [compare lanes 
4 and 5, Fig. 7a(i)]. Notably, depletion of either TDP-43 
or FMRP caused increased levels of Map1b and GluR1 
proteins [Fig. 7a(ii)]. To examine the roles of TDP-43 
and FMRP in the regulation of Map1b and GluR1 at the 
translational level, the distribution patterns of the differ-
ent mRNAs in the sucrose gradients of cell extracts from 
primary hippocampal neurons transfected with the Sc, 
TDP-si or FMRP-si oligos were analyzed [Fig. 7b(i)]. In 
an interesting parallel to the Rac1 mRNA data [Fig. 1a(ii)], 
polysomal accumulation of Map1b mRNA and GluR1 
mRNA at the expense of their association with 40S and 
60S/80S monosomes was evident in TDP-43-depleted or 
FMRP-depleted neurons [see profiles representing results 
of three technical repeats from single biological sample 
in Fig. 7b(i) and histo bar diagram representing results 
from three biological samples in Fig. 7b(ii)], indicative of 
activation of translation upon removal of either FMRP or 
TDP-43. In contrast, polysomal accumulations of CamKII 
mRNA and PSD-95 mRNA were only evident in FMRP-
depleted neurons (Fig. 7b), suggesting no role for TDP-43 
in FMRP-mediated translational inhibition of these two 
mRNAs. Finally, neither TDP-43 nor FMRP had any role 
in the regulation of translation of mTOR mRNA (Fig. 7b).
Interestingly, as exemplified in Fig. 8a(i) and quantita-
tively analyzed in Fig. 8a(ii), the translational co-repres-
sion of Rac1, GluR1 and Map1b mRNAs by TDP-43 and 
FMRP was further supported by the rescue of exogenous 
GFP-FMRP-mediated decreases of Rac1, GluR1 and 
Map1b proteins, but not PSD-95 (data not shown), in DIV 
14 primary hippocampal neurons upon depletion of TDP-
43. Thus, of the five FMRP-regulated target mRNAs we 
analyzed, TDP-43 participated in translational repression 
Fig. 6  TDP-43 assisted recruitment of FMRP in dendritic Rac1 
mRNP complex. Co-localization of Rac1 mRNA with TDP-43, 
FMRP and CYFIP1 proteins in TDP-43- or FMRP-depleted primary 
hippocampal neurons. DIV 14 hippocampal neurons were subjected 
to imaging analysis by FISH using of Rac1 mRNA using probe 1 
(see Supplementary materials and methods for details) and immuno-
fluorescence staining using anti-TDP-43, anti-FMRP or anti-CYFIP1. 
Representative confocal microscope images are shown on the left 
with arrows indicating co-localization of Rac1 mRNA with the three 
proteins. Quantification of the co-localization data from three sets of 
independent experiments (15–20 dendrites for each condition) is rep-
resented as a bar diagram on the right showing the percentages of 
dendritic Rac1 mRNA co-localized with TDP-43, FMRP or CYFIP1 
proteins. Scale bar 5 μm. Significant differences are represented by 
***p < 0.0001 and **p < 0.001 (Student’s t test)
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of three of them, i.e., Rac1, Map1b, and GluR1, but not 
the other two, i.e., CamKII and PSD-95. Furthermore, as 
seen in Fig. 4c and Fig S6, Rac1 mRNA, GluR1 mRNA 
and Map1b mRNA were also associated with CYFIP1-con-
taining RNP complexes in hippocampal neurons in a TDP-
43-dependent and FMRP-dependent manner.
Fig. 7  Binding and translational regulation of dendritic mRNAs by 
FMRP and TDP-43. a i RNA-IP analysis of binding of GluR1(Gria1), 
Map1b, CamKII and mTOR mRNAs with FMRP and TDP-43 pro-
teins in hippocampal neurons transfected with different RNAi oligos. 
Co-immunoprecipitated RNAs were analyzed by semi-quantitative 
(left) or quantitative (right) RT-PCR. Gapdh served as the nega-
tive control (not shown). Representative gel picture of semi-quanti-
tative RT-PCR analysis are depicted on the left with lanes 1, 4 and 
7 showing RNA enrichment in Sc oligo; lanes 2, 5 and 8 showing 
RNA enrichment in TDP-si oligo; and lanes 3, 6 and 9 showing 
RNA enrichment in FMRP-si oligo transfected neurons. Statistical 
analysis of data from three independent experiments is shown on the 
right. Significant differences in fold enrichment of different mRNAs 
between anti-IgG and anti-TDP-43 or anti-FMRP pulled down sam-
ples are represented by ***p < 0.0001 (Student’s t test). ii Relative 
expression levels of Map1b, GluR1, TDP-43 and FMRP proteins in 
cultured hippocampal neurons upon depletion of TDP-43 or FMRP 
by RNAi. Total proteins from DIV 6 primary hippocampal cultures 
transfected with different RNAi oligos for 48 h were subjected to 
Western blotting. Statistical analysis from three independent experi-
ments is shown on the right. Significant differences are represented 
by ***p < 0.0001 (Student’s t test). b Polysomal distributions of dif-
ferent mRNAs in cultured DIV 6 hippocampal neurons transfected 
with different RNAi oligos. i RT-PCR analysis of RNAs isolated 
from different sucrose gradient fractions of cytoplasmic extracts 
from the transfected neurons. The data were plotted as the percentage 
of total mRNA in the gradient. Error bars represent SD from three 
experimental repeats from same set of biological sample. Percentage 
of mRNA level was significantly different between Sc oligo trans-
fected and TDP-si or FMRP-si transfected neurons at 2nd–4th, 8th 
and 9th fractions for Map1b and GluR1 mRNA distributions. It was 
also significantly different between Sc oligo transfected and FMRP-
si transfected neurons at 3rd, 4th and 9th fractions for CamKII and 
PSD-95 mRNA distributions (p < 0.01, pairwise t test). ii Quantitative 
RT-PCR analysis of the indicated mRNAs in polysome fractions of 
DIV 6 primary hippocampal neurons transfected with Sc, TDP-si and 
FMRP-si oligos, respectively. The fold of changes relative to the Sc 
oligo-transfected neurons are represented as the bar diagram. Error 
bars represent SD from three independent experiments with different 
biological samples. Significant differences between Sc oligo trans-
fected and TDP-si or FMRP-si transfected neurons are represented by 
***p < 0.0001 and **p < 0.001 (Student’s t test). Inputs are similar 
(data not shown)
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Functionally, the translational co-repression by FMRP 
and TDP-43 regulated the spinogenesis of the hippocam-
pal neurons. As shown in Fig. 8b, over-expression of GFP-
FMRP decreased the spine density of primary hippocampal 
neurons, but this decrease could be rescued by depletion 
of TDP-43. Thus, the co-operation of TDP-43 with FMRP 
to repress the translation of a class of mRNAs in neurons 
at the initiation step via FMRP-bound CYFIP1 is indeed 
physiologically important with respect to the regulation of 
synaptic plasticity during brain development.
Fig. 8  Co-operation of TDP-43 and FMRP in translational inhibi-
tion of different proteins and spinogenesis in primary hippocam-
pal neurons. a Imaging analysis of the effect of TDP-43 depletion 
on FMRP-mediated inhibition of Rac1, Map1b and GluR1 protein 
expression in DIV 14 neurons. Representative pictures of hippocam-
pal neurons co-transfected with pGFP or pGFP-FMRP plus RNA 
oligo Sc or TDP-si and showing the fluorescence patterns from GFP 
(green) and from immunofluorescence staining of TDP-43 (red), 
Rac1 (orange), GluR1 (blue) and Map1b (white), respectively, are 
displayed in (i). The DIC images of the neurons are shown on the 
right. Scale bars = 2 μm. ii The immunofluorescence intensities of 
Rac1, GluR1 and Map1b in 45–55 transfected neurons from three 
independent experiments were measured and normalized to those 
of the (Sc + GFP) neurons. The fold of changes were calculated 
and shown in the bar diagram. Error bars represent SEM. b Imag-
ing analysis of the effect of TDP-43 depletion on FMRP-mediated 
reduction of the dendritic protrusion density. Representative confo-
cal microscope images of DIV 14 hippocampal neurons transfected 
with Sc oligo + pGFP (top), Sc oligo + pGFP-FMRP (middle) and 
TDP-si oligo + pGFP-FMRP (bottom), respectively, are shown on the 
left, with arrows indicating the dendritic protrusions. Histoplot of the 
average densities of dendritic protrusion of 10–15 neurons from three 
independent experiments is shown on the right. Scale bars 5 μm. c 
Developmental changes in the expression levels of TDP-43, FMRP 
and Rac1 proteins in mouse primary hippocampal neurons in culture. 
Western blotting patterns are shown on the left and statistical analy-
sis is shown on the right. Data represent the mean ± SD (error bars; 
N = 3). Significant differences in a, b and c were determined by one 
way ANOVA ***p < 0.0001, **p < 0.001 and *p < 0.01. d Histop-
lot showing the increased density of dendritic protrusions in cultured 
DIV 6 hippocampal neurons upon RNAi knockdown of TDP-43 or 
FMRP. For each set, 12–16 neurons from three independent experi-
ments have been analyzed. Statistical significances are represented by 
**p < 0.001 and *p < 0.01 (Student’s t test)
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Discussion
Translational repression of dendritic mRNAs is an integral 
part of the regulatory program of neurons to ensure appro-
priate timing and place of the expression of specific den-
dritic proteins, thereby allowing proper spinogenesis and 
synapse formation for neurodevelopment [21, 43]. Impair-
ment of this process, such as in FXS through silencing of 
the translational repressor FMRP, would lead to relief of 
translational repression of many mRNAs and development 
of neurological disorders [18, 59]. In this study, a functional 
and mechanistic synergy between FMRP and the major 
ALS/FTLD pathology related protein TDP-43 in the trans-
lational regulation of a subclass of their common mRNA 
targets important for spinogenesis, synaptic plasticity and/
or neurodevelopment, i.e., Rac1, Map1b and GluR1, has 
been revealed. This synergy correlates well with previous 
findings of co-localization of FMRP and TDP-43 in RNPs 
in hippocampal neurons [67] and their capability to physi-
cally interact with each other [70]. Even more importantly, 
our data provide the molecular basis of a link between neu-
rodevelopmental disorders and TDP-43 proteinopathies.
Initial evidence for the involvement of TDP-43 in trans-
lational repression is that in mouse primary hippocampal 
Fig. 9  A model of translational co-repression of specific mRNA(s) 
by FMRP and TDP-43. a Schematic representation of TDP-43 
engaged in binding with mRNA(s) and FMRP protein. TDP-43 (red) 
binds to UG/GU motifs (black) in the 3′UTR or CDS of the mRNA(s) 
through its RNA-binding domains (RRM1, RRM2). RNA-bound 
TDP-43 also physically interacts with FMRP protein (yellow) through 
its glycine-rich domain and recruits FMRP to the vicinity of the 
mRNA(s). b ON–OFF states of the translation of specific mRNA(s) 
mediated by FMRP and TDP-43. In the “OFF” state, RNA-bound 
TDP-43 (red) recruits FMRP (yellow) or the FMRP-CYFIP1 com-
plex to the vicinity of the mRNA(s). FMRP-bound CYFIP1 (green) 
interacts with eIF4E (blue), thereby blocking eIF4G (grey) from bind-
ing to eIF4E and forming the eIF4F translation initiation complex 
(not shown). Under FMRP-depleted conditions (left lower scheme), 
TDP-43 still binds to UG/GU repeat sequence(s) in the mRNA(s) but 
CYFIP1 (green) can no longer be recruited, thus allowing the forma-
tion of the eIF4E-eIF4G complex at the 5′cap site and ribosome entry 
to start translation. When TDP-43 is depleted (right lower scheme) 
the inhibitory complex CYFIP1-FMRP cannot be recruited to the 
vicinity of the mRNA(s) to repress translation. Note that in either of 
the “ON” states, initiation complex formation between eIF4E and 
eIF4G can still be inhibited by the drug 4EGI-1
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neurons (Fig. 1a) and a non-neuronal HEK293T cell line 
(Fig. 1b), TDP-43 inhibits the distribution of Rac1 mRNA in 
the polysomes and represses the translation of Rac1 mRNA 
[Fig S1c]. Furthermore, the regulation occurs through bind-
ing of TDP-43 to the UG/GU-rich sequences in the 3′UTR of 
Rac1 mRNA via its RRM1/RRM2 domain and subsequent 
recruitment of FMRP to Rac1 mRNP complex (Figs. 2, 3). 
More importantly, this regulation is dependent on FMRP 
[Fig. 1b(ii)], likely through physical interaction between 
FMRP and the glycine-rich domain of TDP-43 (Figs. 3c, 
S3a). Note that in the luciferase reporter assay of translation 
in HEK293T cells, over-expression of FMRP did not inhibit 
translation in the absence of exogenous expression of TDP-
43 protein (Fig. 3c), likely due to the relatively very low level 
of endogenous TDP-43 in the HEK293T cells in comparison 
to mouse hippocampal neurons (Fig S3b).
FMRP represses translation through three different 
pathways [12, 55]. First, it can recruit specific miRNA 
complexes to inhibit translation of specific mRNAs, e.g., 
PSD-95, in neurons in an activity-dependent manner [51]. 
Secondly, FMRP can inhibit translation at the elongation 
stage by directly interacting with the translating ribosomes 
[17]. In this case FMRP protein was found to be mostly 
co-sedimented with higher polysome fractions [11, 60]. 
Finally, and mostly observed in synaptosomes and acti-
vated neurons, FMRP is primarily non-polysomic in nature, 
gets fractionated with translation initiation complex and 
mRNPs, and inhibits the initiation of translation [37, 72]. 
In the latter scenario, FMRP binds specific mRNAs such 
as Rac1, Map1b, CamKII, etc. [48], either directly to the 
G-quadruplex motif in 3′UTR or indirectly with the help 
of as yet to be unidentified factors [12]. This binding leads 
to the physical interaction of the FMRP-binding factor 
CYFIP1 with the initiation factor eIF4E at the 5′-cap site 
of the FMRP-bound mRNA. The formation of the eIF4E-
CYFIP1-FMRP complex inhibits ribosome entry to the 
5′-cap site of the mRNAs [48]. Interestingly, the rate-lim-
iting step of translational co-repression of Rac1 mRNA by 
TDP-43 and FMRP in primary hippocampal neurons and 
HEK293T cells appears to be at the initiation stage (Fig. 4a, 
b) and it requires FMRP-TDP-43 interaction (Fig. 3c). Fur-
thermore, this translational co-repression is closely associ-
ated with complex formation of CYFIP1-FMRP-TDP-43 
(Fig. 4c) and between dendritic Rac1 mRNA with FMRP, 
TDP-43 and CYFIP1 in hippocampal neurons (Figs. 2, 
4c and 6). Thus, our study provides the first evidence that 
repression of mRNAs lacking the G-quadruplex motif, such 
as Rac1 mRNA (Figs. 1, 3, 4, 5b and 8a) and GluR1 mRNA 
(Figs. 7, 8a), requires TDP-43, which acts as an adaptor to 
recruit the repression complex FMRP-CYFIP1 [see model 
of Fig. 9b]. The physiological importance of this co-regula-
tory scheme by the two RBPs is further exemplified by data 
shown in Fig. 8b–d.
Why would FMRP need an adaptor protein like TDP-43 
in the physiological system to select specific mRNA tar-
gets for CYFIP1-mediated translational repression when 
it has its own capacity to bind mRNAs? There are several 
advantageous possibilities. First, FMRP is not likely to 
recognize and bind all mRNAs effectively [12, 72]. TDP-
43 could help recruit the FMRP-CYFIP1 complex to the 
vicinities of mRNAs whether they contain the G-quad-
ruplex motif (e.g., Map1b, Figs. 7a and S6a) or not (e.g., 
Rac1 and GluR1, Figs. 2, 3a, 4c, 6, 7a and S6). Second, 
the requirement for two different RNA-binding proteins in 
translational co-repression allows fine-tuning of the expres-
sion of a class of mRNAs at the translational level, thereby 
facilitating regulation of normal development. For instance, 
the level of FMRP in hippocampal neurons remains rela-
tively unchanged or increases gradually during later stages 
of embryonic development [35], as well as during in vitro 
differentiation (Fig. 8c). This could be required for main-
tenance of the overall expression profiles of FMRP target 
genes. In contrast, the level of TDP-43 gradually decreases, 
while that of Rac1, a positive regulator of spinogenesis [13] 
increases as primary neurons mature in culture (Fig. 8c; 
[45]). Decreased TDP-43 would mitigate TDP-43-FMRP-
CYFIP1-eIF4E-mediated translational repression of den-
dritic Rac1 mRNA (see model in Fig. 9b), thus facilitating 
spinogenesis during neuron maturation (Fig. 8b, d) and 
brain development [13, 45].
The functional synergy of FMRP and TDP-43 in transla-
tional regulation through their physical association in spe-
cific mRNPs (Fig. 9) provides a molecular link between a 
range of neurodevelopmental disorders and several neuro-
degenerative diseases associated with TDP-43 proteinopa-
thies. In particular, a few neurodevelopmental disorders 
exhibit pathological phenotypes overlapping with those 
of FXS, but without apparent involvement of FMRP. For 
example, genetically and biologically, ~20 % of gene/RNA 
targets of FMRP overlap with genes associated with ASDs, 
whereas only up to 5 % of ASD patients carry any type 
of mutation at the FMR1 gene [2, 19]. Notably, neurode-
generation has been reported for a number of ASD cases 
[32] while the molecular basis is unclear. Moreover, based 
on genetic linkage and functional properties, CYFIP1/2 
proteins are good causal candidates for autism, though a 
precise functional role remains to be identified [3]. These 
studies together indicate the involvement of unknown func-
tionally interacting partner(s) of FMRP and CYFIP in ASD 
cases lacking a known gene mutation. Our data suggest that 
TDP-43 might be one of the candidate partners. Based on 
the literature (Table S1), we also speculate that loss-of-
function of either TDP-43 or FMRP leading to the relief of 
translational repression of a subset of their common target 
mRNAs may underlie the pathogenesis of a subclass of AD 
and Schizophrenia. In view of the apparently essential role 
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of FMRP in neuronal functions suggested by studies of 
acute knock down of FMRP in mice [26] or in cell cultures 
([23], current study), the phenotypes of Fmr1 KO mice [31] 
should be more severe than currently known. Perhaps the 
congenital absence of Fmr1 in these Fmr1 KO mice and 
in FXS patients as well has induced some compensatory 
programs or factors in vivo [36]. It would be interesting 
to carry out a comparative study of hippocampal neurons 
from the Fmr1 KO mice, to see whether the co-operative 
scenario of FMRP and TDP-43 in translational co-repres-
sion, as depicted in Fig. 9, is replaced by other regulatory 
scenarios in these neurons. Finally, several ALS-associ-
ated mutations across the glycine-rich domain of TDP-43 
alter its interaction with FMRP (data not shown). Whether 
impairment of the FMRP-TDP-43 interaction has any role 
in the variance in gene expression related to ALS pathology 
could also be an interesting avenue of future research.
We endeavored to identify putative common mRNA tar-
gets of TDP-43 and FMRP, other than those already identi-
fied, some of which might be co-regulated translationally 
by these two RNA binding factors. A comparative analysis 
of the databases of TDP-43-bound mRNAs and FMRP-
bound mRNAs (Table S2) has identified 1140 mRNAs 
as possible common targets of TDP-43 and FMRP. Gene 
ontology analysis identified 160 of these 1140 mRNAs as 
being important for neuron structure, function and devel-
opment (Table S3). However, we could not determine, at 
this moment, which of these 160 mRNAs are co-regulated 
by TDP-43 and FMRP at the translational level, except 
for Rac1 mRNA, GluR1 mRNA and Map1b mRNA (as 
reported above). Interestingly, this gene list also includes 
candidate genes for ASD (e.g., Reln, Shank3, Rac1, Mapk1 
etc.), for AD (e.g., App, Apoe, Ank1, etc.), and for schiz-
ophrenia (e.g., Gsk3b, Grin2b, etc.). This bioinformat-
ics analysis further strengthens the notion that FMRP and 
TDP-43 collaboratively contribute to the pathogenesis of 
different neurodevelopmental disorders and neurodegen-
erative diseases by co-regulating the translation of certain 
members of a common set of their target mRNAs.
In summary, our study has uncovered a paradigm sce-
nario of how TDP-43 regulates the translation of specific 
mRNAs. Furthermore, for the first time, we reveal a func-
tional synergy between FMRP and TDP-43 in translational 
co-repression of a class of neuronal genes important for the 
regulation of spinogenesis, neuron architecture and neu-
ronal plasticity. Loss-of-function of this synergy is likely 
to play a significant role in the pathogenesis of FMRP-
associated neurological disorders, such as ASD and AD, 
and TDP-43-associated neurodegenerative diseases. Since 
mutations or mis-expression of either factor would affect a 
common set of target genes, it will be important to examine 
whether mutations or mis-metabolism of TDP-43 exist in a 
subset of ASD, AD or schizophrenia cases.
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